Lue Y, Sinha Hikim AP, Wang C, et al. Triptolide: a potential male contraceptive. J Androl 1998;19:479-86.. View abstract.
Luk JM, Lai W, Tam P, Koo MW. Suppression of cytokine production and cell adhesion molecule expression in human monocytic cell line THP-1 by Tripterygium wilfordii polysaccharide moiety. Life Sci 2000;67:155-63. View abstract.
Luo Y, Hou X, Xi A, Luo M, Wang K, Xu Z. Tripterygium wilfordii Hook F combination therapy with methotrexate for rheumatoid arthritis: An updated meta-analysis. J Ethnopharmacol 2023;307:116211. View abstract.
Luo Y, Kuai L, Chen J, et al. Efficacy and safety of Tripterygium wilfordii Hook. f. for oral lichen planus: evidence from 18 randomized controlled trials. Phytother Res 2020. Online ahead of print. View abstract.
Lv QW, Zhang W, Shi Q, et al. Comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trial. Ann Rheum Dis. 2015;74(6):1078-86. View abstract.
Qian SZ, Hu YZ, Wang SM, et al. Effects of Tripterygium hypoglaucum (Levl.) Hutch on male fertility. Adv Contracept 1988;4:307-10.. View abstract.
Qiu D, Kao PN. Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. f. Drugs R D 2003;4:1-18.. View abstract.
Ren D, Zuo C, Xu G. Clinical efficacy and safety of Tripterygium wilfordii Hook in the treatment of diabetic kidney disease stage IV: A meta-analysis of randomized controlled trials. Medicine (Baltimore). 2019;98(11):e14604. View abstract.
Ren J, Wu X, Liao N, et al. Prevention of postoperative recurrence of Crohn's disease: Tripterygium wilfordii polyglycoside versus mesalazine. J Int Med Res. 2013;41(1):176-87. View abstract.
Ru Y, Luo Y, Zhou Y, et al. Adverse events associated with treatment of Tripterygium wilfordii Hook F: a quantitative evidence synthesis. Front Pharmacol 2019;10:1250. View abstract.
Shang SL, Cai GY, Duan SW, Li P, Li QG, Chen XM. Retrospective analysis of tacrolimus combined with Tripterygium wilfordii polyglycoside for treating idiopathic membranous nephropathy. BMC Nephrol. 2018 Jul 18;19(1):182. View abstract.
Shi YL, Bai JP, Wang WP. Ion-channels in human sperm membrane and contraceptive mechanisms of male antifertility compounds derived from Chinese traditional medicine. Acta Pharmacol Sin 2003;24:22-30.. View abstract.
Song W, Liu M, Wu J, Zhai H, Chen Y, Peng Z. Preclinical Pharmacokinetics of Triptolide: A Potential Antitumor Drug. Curr Drug Metab. 2019;20(2):147-154. View abstract.
Sun J, Shen X, Dong J, et al. Tripterygium wilfordii Hook F as maintenance treatment for Crohn's disease. Am J Med Sci. 2015;350(5):345-51. View abstract.
Takei A, Nagashima G, Suzuki R, et al. Meningoencephalocele associated with Tripterygium wilfordii treatment. Pediatr Neurosurg 1997;27:45-8. View abstract.
Tao X, Cush JJ, Garret M, Lipsky PE. A phase I study of ethyl acetate extract of the chinese antirheumatic herb Tripterygium wilfordii hook F in rheumatoid arthritis. J Rheumatol 2001;28:2160-7.. View abstract.
Tao X, Davis LS, Lipsky PE. Effect of an extract of the Chinese herbal remedy Tripterygium wilfordii Hook F on human immune responsiveness. Arthritis Rheum 1991;34:1274-81. View abstract.
Tao X, Younger J, Fan FZ, et al. Benefit of an extract of Tripterygium Wilfordii Hook F in patients with rheumatoid arthritis: a double-blind, placebo-controlled study. Arthritis Rheum 2002;46:1735-43.. View abstract.
Tao XL, Sun Y, Dong Y, et al. A prospective, controlled, double-blind, cross-over study of tripterygium wilfodii hook F in treatment of rheumatoid arthritis. Chin Med J 1989;102:327-32. View abstract.
Zemtsov A, Gaddis M, Montalvo-Lugo VM, Zemstov A. Moisturizing and cosmetic properties of emu oil: a pilot double blind study. Australas J Dermatol 1996;37:159-61.